BioEnergenix LLC
Records under this name other than the patents BioEnergenix LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 5 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,459,307 | Heterocyclic Compounds for the Inhibition of Pask Lapsed on the fee record Ended Oct 4, 2026 · Low confidence | Lapsed on the fee record | Ended Oct 4, 2026 | Low confidence |
| US 9,868,708 | Heterocyclic Compounds for the Inhibition of Pask Lapsed on the fee record Ended Jan 16, 2026 · Low confidence | Lapsed on the fee record | Ended Jan 16, 2026 | Low confidence |
| US 11,191,765 | Heterocyclic compounds for the inhibition of PASK Lapsed on the fee record Ended Dec 7, 2025 · From the USPTO record | Lapsed on the fee record | Ended Dec 7, 2025 | From the USPTO record |
| US 9,675,584 | Substituted indoles for the inhibition of PASK Lapsed on the fee record Ended Jun 13, 2025 · From the USPTO record | Lapsed on the fee record | Ended Jun 13, 2025 | From the USPTO record |
| US 10,953,012 | Heterocyclic compounds for the inhibition of pask Lapsed on the fee record Ended Mar 23, 2025 · From the USPTO record | Lapsed on the fee record | Ended Mar 23, 2025 | From the USPTO record |
| US 9,476,881 | Pas Kinase Assays Lapsed on the fee record Ended Oct 25, 2024 · High confidence | Lapsed on the fee record | Ended Oct 25, 2024 | High confidence |
| US 10,781,185 | Heterocyclic Compounds for the Inhibition of Pask Lapsed on the fee record Ended Sep 22, 2024 · Low confidence | Lapsed on the fee record | Ended Sep 22, 2024 | Low confidence |
| US 9,370,522 | Heterocyclic compounds for the inhibition of PASK Lapsed on the fee record Ended Jun 21, 2024 · From the USPTO record | Lapsed on the fee record | Ended Jun 21, 2024 | From the USPTO record |
| US 9,278,973 | Heterocyclic compounds for the inhibition of PASK Lapsed on the fee record Ended Mar 8, 2024 · From the USPTO record | Lapsed on the fee record | Ended Mar 8, 2024 | From the USPTO record |
| US 9,193,693 | Heterocyclic Compounds for the Inhibition of Pask Lapsed on the fee record Ended Nov 24, 2023 · Low confidence | Lapsed on the fee record | Ended Nov 24, 2023 | Low confidence |